Serber Zachariah 4
4 · Zymergen Inc. · Filed Jan 26, 2022
Insider Transaction Report
Form 4
Serber Zachariah
DirectorChief Science Officer
Transactions
- Sale
Common Stock
2022-01-24$4.76/sh−21,730$103,446→ 2,391,220 total
Holdings
- 40,000(indirect: See Footnote)
Common Stock
- 40,000(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2021 that provides for the sale of up to 250,000 shares over the next ten (10) months.
- [F2]Transaction executed in multiple trades at prices ranging from $4.50 to $5.05 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Held by the Rorik Serber 2021 Irrevocable Trust.
- [F4]Held by spouse as custodian for children under the California Uniform Transfer to Minors Act.